SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 445.28 |
Enterprise Value ($M) | 385.28 |
Book Value ($M) | -35.48 |
Book Value / Share | -0.39 |
Price / Book | -12.55 |
NCAV ($M) | -49.07 |
NCAV / Share | -0.54 |
Price / NCAV | -9.07 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -105.41 |
Return on Assets (ROA) | -0.43 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.98 |
Current Ratio | 7.49 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 104.01 |
Assets | 117.61 |
Liabilities | 153.08 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Venrock Healthcare Capital Partners III, L.P. | 6.50 | ||
13G | Armistice Capital, Llc | 5.88 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
106,233 | 648,450 | 16.38 | |
169,379 | 743,977 | 22.77 | |
331,354 | 1,101,146 | 30.09 | |
321,782 | 923,016 | 34.86 | |
(click for more detail) |
Similar Companies | |
---|---|
ANIP – ANI Pharmaceuticals, Inc. | APGE – Apogee Therapeutics, Inc. |
APLT – Applied Therapeutics, Inc. | ARCT – Arcturus Therapeutics Holdings Inc. |
ARDX – Ardelyx, Inc. |
Financial data and stock pages provided by
Fintel.io